Chemokines (CCL3 and CCL5) and other proangiogenic factors also upregulate VEGF and promote neovasculature in osteosarcoma [111,112,113], and high expression of VEGF and VEGFR2 is associated with poor prognosis [114,115,116]. Here, CCL5 is linked to osteosarcoma.